These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
o
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
Leidos Holdings, Inc.
|
|
|
(Exact name of registrant as specified in its charter)
|
|
|
|
Delaware
|
|
20-3562868
|
|
(State or other jurisdiction of incorporation or organization)
|
|
(I.R.S. Employer Identification No.)
|
|
|
|
|
|
11951 Freedom Drive, Reston, Virginia
|
|
20190
|
|
(Address of principal executive office)
|
|
(Zip Code)
|
|
|
|
|
|
(571) 526-6000
|
||
|
(Registrant's telephone number, including area code)
|
||
|
|
Large accelerated filer
|
x
|
|
|
|
|
Accelerated filer
|
o
|
|
|
|
Non-accelerated filer
|
o
|
(Do not check if a smaller reporting company)
|
|
Smaller reporting company
|
o
|
|
||
|
|
|
|
|
|
|
|
Emerging growth company
|
o
|
|
|
|
|
Page
|
|
Part I
|
|
|
|
|
|
|
|
Item 1.
|
||
|
|
|
|
|
Item 2.
|
||
|
|
|
|
|
Item 3.
|
||
|
|
|
|
|
Item 4.
|
||
|
|
|
|
|
Part II
|
|
|
|
|
|
|
|
Item 1.
|
||
|
|
|
|
|
Item 1A.
|
||
|
|
|
|
|
Item 2.
|
||
|
|
|
|
|
Item 3.
|
||
|
|
|
|
|
Item 4.
|
||
|
|
|
|
|
Item 5.
|
||
|
|
|
|
|
Item 6.
|
||
|
|
|
|
|
|
||
|
|
|
March 30,
2018 |
|
December 29,
2017 |
||||
|
|
|
(in millions)
|
||||||
|
ASSETS
|
|
|
|
|
||||
|
Current assets:
|
|
|
|
|
||||
|
Cash and cash equivalents
|
|
$
|
215
|
|
|
$
|
390
|
|
|
Receivables, net
|
|
1,914
|
|
|
1,831
|
|
||
|
Inventory, prepaid expenses and other current assets
|
|
506
|
|
|
453
|
|
||
|
Total current assets
|
|
2,635
|
|
|
2,674
|
|
||
|
Property, plant and equipment, net
|
|
227
|
|
|
232
|
|
||
|
Intangible assets, net
|
|
806
|
|
|
856
|
|
||
|
Goodwill
|
|
4,976
|
|
|
4,974
|
|
||
|
Other assets
|
|
269
|
|
|
254
|
|
||
|
|
|
$
|
8,913
|
|
|
$
|
8,990
|
|
|
LIABILITIES AND EQUITY
|
|
|
|
|
||||
|
Current liabilities:
|
|
|
|
|
||||
|
Accounts payable and accrued liabilities
|
|
$
|
1,622
|
|
|
$
|
1,639
|
|
|
Accrued payroll and employee benefits
|
|
379
|
|
|
487
|
|
||
|
Dividends payable
|
|
14
|
|
|
17
|
|
||
|
Income taxes payable
|
|
7
|
|
|
4
|
|
||
|
Long-term debt, current portion
|
|
81
|
|
|
55
|
|
||
|
Total current liabilities
|
|
2,103
|
|
|
2,202
|
|
||
|
Long-term debt, net of current portion
|
|
3,007
|
|
|
3,056
|
|
||
|
Deferred tax liabilities
|
|
221
|
|
|
220
|
|
||
|
Other long-term liabilities
|
|
148
|
|
|
129
|
|
||
|
Commitments and contingencies (Notes 20 and 21)
|
|
|
|
|
||||
|
Stockholders’ equity:
|
|
|
|
|
||||
|
Common stock, $.0001 par value, 500 million shares authorized, 152 million and 151 million shares issued and outstanding at March 30, 2018 and December 29, 2017, respectively
|
|
—
|
|
|
—
|
|
||
|
Additional paid-in capital
|
|
3,338
|
|
|
3,344
|
|
||
|
Accumulated earnings (deficit)
|
|
37
|
|
|
(7
|
)
|
||
|
Accumulated other comprehensive income
|
|
56
|
|
|
33
|
|
||
|
Total Leidos stockholders’ equity
|
|
3,431
|
|
|
3,370
|
|
||
|
Non-controlling interest
|
|
3
|
|
|
13
|
|
||
|
Total equity
|
|
3,434
|
|
|
3,383
|
|
||
|
|
|
$
|
8,913
|
|
|
$
|
8,990
|
|
|
|
|
Three Months Ended
|
||||||
|
|
|
March 30,
2018 |
|
March 31,
2017 |
||||
|
|
|
(in millions, except per share amounts)
|
||||||
|
Revenues
|
|
$
|
2,443
|
|
|
$
|
2,580
|
|
|
Cost of revenues
|
|
2,086
|
|
|
2,233
|
|
||
|
Selling, general and administrative expenses
|
|
178
|
|
|
181
|
|
||
|
Acquisition and integration costs
|
|
11
|
|
|
19
|
|
||
|
Asset impairment charges
|
|
7
|
|
|
—
|
|
||
|
Restructuring expenses
|
|
6
|
|
|
13
|
|
||
|
Equity earnings of non-consolidated subsidiaries
|
|
(4
|
)
|
|
(7
|
)
|
||
|
Operating income
|
|
159
|
|
|
141
|
|
||
|
Interest expense, net
|
|
(34
|
)
|
|
(36
|
)
|
||
|
Other income, net
|
|
—
|
|
|
3
|
|
||
|
Income before income taxes
|
|
125
|
|
|
108
|
|
||
|
Income tax expense
|
|
(23
|
)
|
|
(34
|
)
|
||
|
Net income
|
|
102
|
|
|
74
|
|
||
|
Less: net income attributable to non-controlling interest
|
|
—
|
|
|
2
|
|
||
|
Net income attributable to Leidos common stockholders
|
|
$
|
102
|
|
|
$
|
72
|
|
|
Earnings per share:
|
|
|
|
|
||||
|
Basic
|
|
$
|
0.67
|
|
|
$
|
0.48
|
|
|
Diluted
|
|
0.66
|
|
|
0.47
|
|
||
|
|
|
|
|
|
||||
|
Cash dividends declared per share
|
|
$
|
0.32
|
|
|
$
|
0.32
|
|
|
|
|
Three Months Ended
|
||||||
|
|
|
March 30,
2018 |
|
March 31,
2017 |
||||
|
|
|
(in millions)
|
||||||
|
Net income
|
|
$
|
102
|
|
|
$
|
74
|
|
|
Other comprehensive income, net of taxes:
|
|
|
|
|
||||
|
Foreign currency translation adjustments
|
|
4
|
|
|
11
|
|
||
|
Unrecognized gain on derivative instruments (Note 15)
|
|
10
|
|
|
1
|
|
||
|
Total other comprehensive income, net of taxes
|
|
14
|
|
|
12
|
|
||
|
Comprehensive income
|
|
116
|
|
|
86
|
|
||
|
Less: comprehensive income attributable to non-controlling interest
|
|
—
|
|
|
2
|
|
||
|
Comprehensive income attributable to Leidos common stockholders
|
|
$
|
116
|
|
|
$
|
84
|
|
|
|
|
Shares of common stock
|
|
Additional
paid-in capital |
|
Accumulated earnings (deficit)
|
|
Accumulated
other comprehensive income |
|
Leidos Holdings, Inc. stockholders' equity
|
|
Non-controlling interest
|
|
Total
|
|||||||||||||
|
|
|
(in millions, except for per share amounts)
|
|||||||||||||||||||||||||
|
Balance at December 30, 2016
|
|
150
|
|
|
$
|
3,316
|
|
|
$
|
(177
|
)
|
|
$
|
(4
|
)
|
|
$
|
3,135
|
|
|
$
|
12
|
|
|
$
|
3,147
|
|
|
Net income
|
|
—
|
|
|
—
|
|
|
72
|
|
|
—
|
|
|
72
|
|
|
2
|
|
|
74
|
|
||||||
|
Other comprehensive income, net of taxes
|
|
—
|
|
|
—
|
|
|
—
|
|
|
12
|
|
|
12
|
|
|
—
|
|
|
12
|
|
||||||
|
Issuances of stock
|
|
1
|
|
|
3
|
|
|
—
|
|
|
—
|
|
|
3
|
|
|
—
|
|
|
3
|
|
||||||
|
Repurchases of stock and other
|
|
—
|
|
|
(6
|
)
|
|
—
|
|
|
—
|
|
|
(6
|
)
|
|
—
|
|
|
(6
|
)
|
||||||
|
Dividends declared
|
|
—
|
|
|
—
|
|
|
(49
|
)
|
|
—
|
|
|
(49
|
)
|
|
—
|
|
|
(49
|
)
|
||||||
|
Stock-based compensation
|
|
—
|
|
|
10
|
|
|
—
|
|
|
—
|
|
|
10
|
|
|
—
|
|
|
10
|
|
||||||
|
Adjustment to original purchase price allocation
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(3
|
)
|
|
(3
|
)
|
||||||
|
Balance at March 31, 2017
|
|
151
|
|
|
$
|
3,323
|
|
|
$
|
(154
|
)
|
|
$
|
8
|
|
|
$
|
3,177
|
|
|
$
|
11
|
|
|
$
|
3,188
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
|
Balance at December 29, 2017
|
|
151
|
|
|
$
|
3,344
|
|
|
$
|
(7
|
)
|
|
$
|
33
|
|
|
$
|
3,370
|
|
|
$
|
13
|
|
|
$
|
3,383
|
|
|
Cumulative adjustments related to ASU adoptions (Note 2)
|
|
—
|
|
|
—
|
|
|
(8
|
)
|
|
9
|
|
|
1
|
|
|
—
|
|
|
1
|
|
||||||
|
Balance at December 30, 2017
|
|
151
|
|
|
3,344
|
|
|
(15
|
)
|
|
42
|
|
|
3,371
|
|
|
13
|
|
|
3,384
|
|
||||||
|
Net income
|
|
—
|
|
|
—
|
|
|
102
|
|
|
—
|
|
|
102
|
|
|
—
|
|
|
102
|
|
||||||
|
Other comprehensive income, net of taxes (Note 15)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
14
|
|
|
14
|
|
|
—
|
|
|
14
|
|
||||||
|
Issuances of stock
|
|
1
|
|
|
5
|
|
|
—
|
|
|
—
|
|
|
5
|
|
|
—
|
|
|
5
|
|
||||||
|
Repurchases of stock and other
|
|
—
|
|
|
(22
|
)
|
|
—
|
|
|
—
|
|
|
(22
|
)
|
|
—
|
|
|
(22
|
)
|
||||||
|
Dividends declared
|
|
—
|
|
|
—
|
|
|
(50
|
)
|
|
—
|
|
|
(50
|
)
|
|
—
|
|
|
(50
|
)
|
||||||
|
Stock-based compensation
|
|
—
|
|
|
11
|
|
|
—
|
|
|
—
|
|
|
11
|
|
|
—
|
|
|
11
|
|
||||||
|
Purchase of non-controlling interests
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(10
|
)
|
|
(10
|
)
|
||||||
|
Balance at March 30, 2018
|
|
152
|
|
|
$
|
3,338
|
|
|
$
|
37
|
|
|
$
|
56
|
|
|
$
|
3,431
|
|
|
$
|
3
|
|
|
$
|
3,434
|
|
|
|
|
Three Months Ended
|
||||||
|
|
|
March 30,
2018 |
|
March 31,
2017 |
||||
|
|
|
(in millions)
|
||||||
|
Cash flows from operations:
|
|
|
|
|
||||
|
Net income
|
|
$
|
102
|
|
|
$
|
74
|
|
|
Adjustments to reconcile net income to net cash provided by (used in) operations:
|
|
|
|
|
||||
|
Depreciation and amortization
|
|
63
|
|
|
82
|
|
||
|
Stock-based compensation
|
|
11
|
|
|
10
|
|
||
|
Asset impairment charges
|
|
7
|
|
|
—
|
|
||
|
Other
|
|
7
|
|
|
3
|
|
||
|
Change in assets and liabilities, net of effects of acquisitions and dispositions:
|
|
|
|
|
||||
|
Receivables
|
|
(84
|
)
|
|
(190
|
)
|
||
|
Inventory, prepaid expenses and other current assets
|
|
(63
|
)
|
|
22
|
|
||
|
Accounts payable and accrued liabilities
|
|
60
|
|
|
(37
|
)
|
||
|
Accrued payroll and employee benefits
|
|
(107
|
)
|
|
(86
|
)
|
||
|
Deferred income taxes and income taxes receivable/payable
|
|
28
|
|
|
31
|
|
||
|
Other long-term assets/liabilities
|
|
(2
|
)
|
|
20
|
|
||
|
Net cash provided by (used in) operating activities
|
|
22
|
|
|
(71
|
)
|
||
|
Cash flows from investing activities:
|
|
|
|
|
||||
|
Payments for property, plant and equipment
|
|
(15
|
)
|
|
(7
|
)
|
||
|
Acquisitions of businesses
|
|
(81
|
)
|
|
—
|
|
||
|
Other
|
|
—
|
|
|
2
|
|
||
|
Net cash used in investing activities
|
|
(96
|
)
|
|
(5
|
)
|
||
|
Cash flows from financing activities:
|
|
|
|
|
||||
|
Payments of long-term debt
|
|
(17
|
)
|
|
(22
|
)
|
||
|
Proceeds from issuances of stock
|
|
4
|
|
|
1
|
|
||
|
Repurchases of stock and other
|
|
(22
|
)
|
|
(6
|
)
|
||
|
Dividend payments
|
|
(52
|
)
|
|
(50
|
)
|
||
|
Other
|
|
(4
|
)
|
|
(1
|
)
|
||
|
Net cash used in financing activities
|
|
(91
|
)
|
|
(78
|
)
|
||
|
Net decrease in cash, cash equivalents and restricted cash
|
|
(165
|
)
|
|
(154
|
)
|
||
|
Cash, cash equivalents and restricted cash at beginning of period
|
|
422
|
|
|
396
|
|
||
|
Cash, cash equivalents and restricted cash at end of period
|
|
$
|
257
|
|
|
$
|
242
|
|
|
|
|
Balance at December 29, 2017
|
|
Adjustments due to ASU 2014-09
|
|
Adjustments due to ASU 2017-12
|
|
Adjustments due to ASU 2018-02
|
|
Balance at December 30, 2017
|
||||||||||
|
|
|
(in millions)
|
||||||||||||||||||
|
Assets:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Receivables, net
|
|
$
|
1,831
|
|
|
$
|
4
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
1,835
|
|
|
Inventory, prepaid expenses and other current assets
|
|
453
|
|
|
(3
|
)
|
|
—
|
|
|
—
|
|
|
450
|
|
|||||
|
Equity:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Accumulated deficit
|
|
$
|
(7
|
)
|
|
$
|
1
|
|
|
$
|
(3
|
)
|
|
$
|
(6
|
)
|
|
$
|
(15
|
)
|
|
Accumulated other comprehensive income
|
|
33
|
|
|
—
|
|
|
3
|
|
|
6
|
|
|
42
|
|
|||||
|
|
|
Three Months Ended
|
||||||
|
|
|
March 30,
2018 |
|
March 31,
2017 |
||||
|
|
|
(in millions, except per share amounts)
|
||||||
|
Net favorable impact to income before income taxes
|
|
$
|
35
|
|
|
$
|
22
|
|
|
Impact on diluted EPS attributable to Leidos common stockholders
|
|
$
|
0.17
|
|
|
$
|
0.09
|
|
|
|
|
As Reported (ASC 606)
|
|
As Adjusted
(ASC 605)
|
||||
|
|
|
(in millions)
|
||||||
|
Balance sheet:
|
|
|
|
|
||||
|
Receivables, net
|
|
$
|
1,914
|
|
|
$
|
1,909
|
|
|
Inventory, prepaid expenses and other current assets
|
|
506
|
|
|
509
|
|
||
|
Accumulated earnings (deficit)
|
|
37
|
|
|
35
|
|
||
|
|
|
|
|
|
||||
|
Income statement:
|
|
|
|
|
||||
|
Revenues
|
|
$
|
2,443
|
|
|
$
|
2,438
|
|
|
Cost of revenues
|
|
2,086
|
|
|
2,083
|
|
||
|
Operating income
|
|
159
|
|
|
157
|
|
||
|
|
|
Three Months Ended March 30, 2018
|
||||||||||||||
|
|
|
Defense Solutions
|
|
Civil
|
|
Health
|
|
Total
|
||||||||
|
|
|
(in millions)
|
||||||||||||||
|
DoD
|
|
$
|
1,032
|
|
|
$
|
23
|
|
|
$
|
92
|
|
|
$
|
1,147
|
|
|
Other government agencies
(1)
|
|
45
|
|
|
589
|
|
|
298
|
|
|
932
|
|
||||
|
Commercial and non-U.S. customers
|
|
101
|
|
|
228
|
|
|
35
|
|
|
364
|
|
||||
|
Total
|
|
$
|
1,178
|
|
|
$
|
840
|
|
|
$
|
425
|
|
|
$
|
2,443
|
|
|
|
|
Three Months Ended March 30, 2018
|
||||||||||||||
|
|
|
Defense Solutions
|
|
Civil
|
|
Health
|
|
Total
|
||||||||
|
|
|
(in millions)
|
||||||||||||||
|
Cost-reimbursement and fixed-price-incentive- fee
|
|
$
|
771
|
|
|
$
|
439
|
|
|
$
|
50
|
|
|
$
|
1,260
|
|
|
Firm-fixed-price
|
|
283
|
|
|
256
|
|
|
253
|
|
|
792
|
|
||||
|
Time-and-materials and fixed-price-level-of-effort
|
|
124
|
|
|
145
|
|
|
122
|
|
|
391
|
|
||||
|
Total
|
|
$
|
1,178
|
|
|
$
|
840
|
|
|
$
|
425
|
|
|
$
|
2,443
|
|
|
|
|
Three Months Ended March 30, 2018
|
||||||||||||||
|
|
|
Defense Solutions
|
|
Civil
|
|
Health
|
|
Total
|
||||||||
|
|
|
(in millions)
|
||||||||||||||
|
United States
|
|
$
|
1,088
|
|
|
$
|
696
|
|
|
$
|
425
|
|
|
$
|
2,209
|
|
|
International
|
|
90
|
|
|
144
|
|
|
—
|
|
|
234
|
|
||||
|
Total
|
|
$
|
1,178
|
|
|
$
|
840
|
|
|
$
|
425
|
|
|
$
|
2,443
|
|
|
|
|
Balance sheet line item
|
|
March 30,
2018 |
|
December 30, 2017
(1)
|
||||
|
|
|
|
|
(in millions)
|
||||||
|
Contract assets - current:
|
|
|
|
|
|
|
||||
|
Unbilled receivables
(2)
|
|
Receivables, net
|
|
$
|
836
|
|
|
$
|
844
|
|
|
Transition costs and project assets
|
|
Inventory, prepaid expenses and other current assets
|
|
114
|
|
|
59
|
|
||
|
|
|
|
|
$
|
950
|
|
|
$
|
903
|
|
|
|
|
|
|
|
|
|
||||
|
Contract assets - non-current:
|
|
|
|
|
|
|
||||
|
Transition costs and project assets
|
|
Other assets
|
|
$
|
14
|
|
|
$
|
13
|
|
|
|
|
|
|
|
|
|
||||
|
Contract liabilities - current:
|
|
|
|
|
|
|
||||
|
Deferred revenue
|
|
Accounts payable and accrued liabilities
|
|
$
|
406
|
|
|
$
|
293
|
|
|
|
|
|
|
|
|
|
||||
|
Contract liabilities - non-current:
|
|
|
|
|
|
|
||||
|
Deferred revenue
|
|
Other long-term liabilities
|
|
$
|
22
|
|
|
$
|
17
|
|
|
|
|
Three Months Ended
|
||||||
|
|
|
March 30,
2018 |
|
March 31,
2017 |
||||
|
|
|
(in millions)
|
||||||
|
Acquisition costs
|
|
$
|
—
|
|
|
$
|
1
|
|
|
Integration costs
|
|
11
|
|
|
18
|
|
||
|
Total acquisition and integration costs
|
|
$
|
11
|
|
|
$
|
19
|
|
|
|
|
Three Months Ended
|
||||||
|
|
|
March 30,
2018 |
|
March 31,
2017 |
||||
|
|
|
(in millions)
|
||||||
|
Severance costs
|
|
$
|
1
|
|
|
$
|
10
|
|
|
Lease termination expenses
|
|
5
|
|
|
3
|
|
||
|
Restructuring expenses related to the IS&GS Business
|
|
$
|
6
|
|
|
$
|
13
|
|
|
|
|
Severance Costs
|
|
Lease Termination Expenses
|
|
Total
|
||||||
|
|
|
(in millions)
|
||||||||||
|
Balance as of December 30, 2016
|
|
$
|
7
|
|
|
$
|
1
|
|
|
$
|
8
|
|
|
Charges
|
|
18
|
|
|
19
|
|
|
37
|
|
|||
|
Cash payments
|
|
(20
|
)
|
|
(16
|
)
|
|
(36
|
)
|
|||
|
Balance as of December 29, 2017
|
|
5
|
|
|
4
|
|
|
9
|
|
|||
|
Charges
|
|
1
|
|
|
5
|
|
|
6
|
|
|||
|
Cash payments
|
|
(4
|
)
|
|
(4
|
)
|
|
(8
|
)
|
|||
|
Balance as of March 30, 2018
|
|
$
|
2
|
|
|
$
|
5
|
|
|
$
|
7
|
|
|
|
|
March 30, 2018
|
|
December 29, 2017
|
||||||||||||
|
|
|
Carrying value
|
|
Fair value
|
|
Carrying value
|
|
Fair value
|
||||||||
|
|
|
(in millions)
|
||||||||||||||
|
Financial assets:
|
|
|
|
|
|
|
|
|
||||||||
|
Derivatives
|
|
$
|
51
|
|
|
$
|
51
|
|
|
$
|
37
|
|
|
$
|
37
|
|
|
Financial liabilities:
|
|
|
|
|
|
|
|
|
||||||||
|
Derivatives
|
|
7
|
|
|
7
|
|
|
—
|
|
|
—
|
|
||||
|
|
|
Defense Solutions
|
|
Civil
|
|
Health
|
|
Total
|
||||||||
|
|
|
(in millions)
|
||||||||||||||
|
Goodwill at December 30, 2016
|
|
$
|
1,954
|
|
|
$
|
1,731
|
|
|
$
|
937
|
|
|
$
|
4,622
|
|
|
Adjustment to original purchase price allocation
|
|
94
|
|
|
259
|
|
|
(16
|
)
|
|
337
|
|
||||
|
Foreign currency translation adjustments
|
|
7
|
|
|
8
|
|
|
—
|
|
|
15
|
|
||||
|
Goodwill at December 29, 2017
|
|
2,055
|
|
|
1,998
|
|
|
921
|
|
|
4,974
|
|
||||
|
Foreign currency translation adjustments
|
|
(6
|
)
|
|
8
|
|
|
—
|
|
|
2
|
|
||||
|
Goodwill at March 30, 2018
|
|
$
|
2,049
|
|
|
$
|
2,006
|
|
|
$
|
921
|
|
|
$
|
4,976
|
|
|
|
|
March 30, 2018
|
|
December 29, 2017
|
||||||||||||||||||||
|
|
|
Gross carrying value
|
|
Accumulated amortization
|
|
Net carrying value
|
|
Gross carrying value
|
|
Accumulated amortization
|
|
Net carrying value
|
||||||||||||
|
|
|
(in millions)
|
||||||||||||||||||||||
|
Finite-lived intangible assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Program and contract intangibles
|
|
$
|
1,013
|
|
|
$
|
(235
|
)
|
|
$
|
778
|
|
|
$
|
1,013
|
|
|
$
|
(187
|
)
|
|
$
|
826
|
|
|
Software and technology
|
|
89
|
|
|
(66
|
)
|
|
23
|
|
|
89
|
|
|
(64
|
)
|
|
25
|
|
||||||
|
Customer relationships
|
|
4
|
|
|
(3
|
)
|
|
1
|
|
|
4
|
|
|
(3
|
)
|
|
1
|
|
||||||
|
Backlog
|
|
—
|
|
|
—
|
|
|
—
|
|
|
158
|
|
|
(158
|
)
|
|
—
|
|
||||||
|
Total finite-lived intangible assets
|
|
1,106
|
|
|
(304
|
)
|
|
802
|
|
|
1,264
|
|
|
(412
|
)
|
|
852
|
|
||||||
|
Indefinite-lived intangible assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Trade names
|
|
4
|
|
|
—
|
|
|
4
|
|
|
4
|
|
|
—
|
|
|
4
|
|
||||||
|
Total intangible assets
|
|
$
|
1,110
|
|
|
$
|
(304
|
)
|
|
$
|
806
|
|
|
$
|
1,268
|
|
|
$
|
(412
|
)
|
|
$
|
856
|
|
|
Fiscal Year Ending
|
|
|
||
|
|
|
(in millions)
|
||
|
2018 (remainder of year)
|
|
$
|
151
|
|
|
2019
|
|
173
|
|
|
|
2020
|
|
128
|
|
|
|
2021
|
|
106
|
|
|
|
2022
|
|
92
|
|
|
|
2023 and thereafter
|
|
152
|
|
|
|
|
|
$
|
802
|
|
|
|
|
March 30,
2018 |
|
December 29,
2017 |
||||
|
|
|
(in millions)
|
||||||
|
Computers and other equipment
|
|
$
|
196
|
|
|
$
|
194
|
|
|
Leasehold improvements
|
|
172
|
|
|
171
|
|
||
|
Buildings and improvements
|
|
56
|
|
|
54
|
|
||
|
Office furniture and fixtures
|
|
34
|
|
|
34
|
|
||
|
Land
|
|
40
|
|
|
49
|
|
||
|
Construction in progress
|
|
55
|
|
|
44
|
|
||
|
|
|
553
|
|
|
546
|
|
||
|
Less: accumulated depreciation and amortization
|
|
(326
|
)
|
|
(314
|
)
|
||
|
|
|
$
|
227
|
|
|
$
|
232
|
|
|
|
|
Asset Derivatives
|
||||||
|
|
|
Balance sheet line item
|
|
March 30,
2018 |
|
December 29,
2017 |
||
|
|
|
|
|
(in millions)
|
||||
|
Cash flow interest rate swaps
|
|
Other assets
|
|
51
|
|
|
37
|
|
|
|
|
Liability Derivatives
|
||||||||
|
|
|
Balance sheet line item
|
|
March 30,
2018 |
|
December 29,
2017 |
||||
|
|
|
|
|
(in millions)
|
||||||
|
Fair value interest rate swaps
|
|
Other long-term liabilities
|
|
$
|
6
|
|
|
$
|
—
|
|
|
Cash flow interest rate swaps
|
|
Other long-term liabilities
|
|
1
|
|
|
—
|
|
||
|
|
|
|
|
$
|
7
|
|
|
$
|
—
|
|
|
|
|
Carrying amount of hedged item
|
|
Cumulative amount of fair value adjustment included within the hedged item
|
||||||||||||
|
Balance sheet line item of hedged item
|
|
March 30,
2018 |
|
December 29,
2017 |
|
March 30,
2018 |
|
December 29,
2017 |
||||||||
|
|
|
(in millions)
|
||||||||||||||
|
Long-term debt, net of current portion
|
|
$
|
443
|
|
|
$
|
449
|
|
|
$
|
(6
|
)
|
|
$
|
—
|
|
|
|
|
Three Months Ended
|
||||||
|
|
|
March 30,
2018 |
|
March 31,
2017 |
||||
|
|
|
(in millions)
|
||||||
|
Total interest expense, net presented in the condensed consolidated statements of income in which the effects of cash flow hedges are recorded
|
|
$
|
34
|
|
|
$
|
36
|
|
|
|
|
|
|
|
||||
|
Amount recognized in other comprehensive income
|
|
14
|
|
|
1
|
|
||
|
Amount reclassified from accumulated other comprehensive income to interest expense, net
|
|
(1
|
)
|
|
1
|
|
||
|
|
|
Stated interest rate
|
|
Effective interest rate
|
|
March 30, 2018
(1)
|
|
December 29, 2017
(1)
|
||||
|
|
|
|
|
|
|
(in millions)
|
||||||
|
Senior secured notes:
|
|
|
|
|
|
|
|
|
||||
|
$450 million notes, due December 2020
|
|
4.45%
|
|
4.53%
|
|
$
|
443
|
|
|
$
|
449
|
|
|
$300 million notes, due December 2040
|
|
5.95%
|
|
6.03%
|
|
216
|
|
|
216
|
|
||
|
Senior secured term loans:
|
|
|
|
|
|
|
|
|
||||
|
$690 million Term Loan A, due August 2022
|
|
3.69%
|
|
4.18%
|
|
636
|
|
|
644
|
|
||
|
$310 million Term Loan A, due August 2022
|
|
3.69%
|
|
4.18%
|
|
267
|
|
|
270
|
|
||
|
$1,131 million Term Loan B, due August 2023
|
|
3.69%
|
|
4.07%
|
|
1,098
|
|
|
1,101
|
|
||
|
Senior unsecured notes:
|
|
|
|
|
|
|
|
|
||||
|
$250 million notes, due July 2032
|
|
7.13%
|
|
7.43%
|
|
246
|
|
|
246
|
|
||
|
$300 million notes, due July 2033
|
|
5.50%
|
|
5.88%
|
|
158
|
|
|
158
|
|
||
|
Capital leases and notes payable due on various dates through fiscal 2022
|
|
0%-5.55%
|
|
Various
|
|
24
|
|
|
27
|
|
||
|
Total long-term debt
|
|
|
|
|
|
3,088
|
|
|
3,111
|
|
||
|
Less: current portion
|
|
|
|
|
|
81
|
|
|
55
|
|
||
|
Total long-term debt, net of current portion
|
|
|
|
|
|
$
|
3,007
|
|
|
$
|
3,056
|
|
|
|
|
Foreign currency translation adjustments
|
|
Unrecognized gain on derivative instruments
|
|
Pension adjustments
|
|
Total accumulated other comprehensive income
|
||||||||
|
|
|
(in millions)
|
||||||||||||||
|
Balance at December 30, 2016
|
|
$
|
(7
|
)
|
|
$
|
10
|
|
|
$
|
(7
|
)
|
|
$
|
(4
|
)
|
|
Other comprehensive income
|
|
36
|
|
|
10
|
|
|
9
|
|
|
55
|
|
||||
|
Taxes
|
|
(12
|
)
|
|
(6
|
)
|
|
—
|
|
|
(18
|
)
|
||||
|
Balance at December 29, 2017
|
|
17
|
|
|
14
|
|
|
2
|
|
|
33
|
|
||||
|
Cumulative adjustments related to ASU adoptions (Note 2)
|
|
3
|
|
|
10
|
|
|
(4
|
)
|
|
9
|
|
||||
|
Balance at December 30, 2017
|
|
20
|
|
|
24
|
|
|
(2
|
)
|
|
42
|
|
||||
|
Other comprehensive income
|
|
3
|
|
|
14
|
|
|
—
|
|
|
17
|
|
||||
|
Taxes
|
|
1
|
|
|
(3
|
)
|
|
—
|
|
|
(2
|
)
|
||||
|
Reclassification from accumulated other comprehensive income
|
|
—
|
|
|
(1
|
)
|
|
—
|
|
|
(1
|
)
|
||||
|
Balance at March 30, 2018
|
|
$
|
24
|
|
|
$
|
34
|
|
|
$
|
(2
|
)
|
|
$
|
56
|
|
|
|
|
Three Months Ended
|
||||
|
|
|
March 30,
2018 |
|
March 31,
2017 |
||
|
|
|
(in millions)
|
||||
|
Basic weighted average number of shares outstanding
|
|
152
|
|
|
150
|
|
|
Dilutive common share equivalents—stock options and other stock awards
|
|
2
|
|
|
3
|
|
|
Diluted weighted average number of shares outstanding
|
|
154
|
|
|
153
|
|
|
|
|
Three Months Ended
|
||||||
|
|
|
March 30,
2018 |
|
March 31,
2017 |
||||
|
|
|
(in millions)
|
||||||
|
Supplementary cash flow information:
|
|
|
|
|
||||
|
Cash paid for interest
|
|
$
|
32
|
|
|
$
|
32
|
|
|
Cash paid for income taxes, net of refunds
|
|
2
|
|
|
1
|
|
||
|
Non-cash financing activity:
|
|
|
|
|
||||
|
Capital lease obligation
|
|
—
|
|
|
6
|
|
||
|
Purchase of non-controlling interests
|
|
7
|
|
|
—
|
|
||
|
|
|
March 30,
2018 |
|
December 29,
2017 |
||||
|
|
|
(in millions)
|
||||||
|
Cash and cash equivalents
|
|
$
|
215
|
|
|
$
|
390
|
|
|
Restricted cash
|
|
42
|
|
|
32
|
|
||
|
Total cash, cash equivalents and restricted cash
|
|
$
|
257
|
|
|
$
|
422
|
|
|
|
|
Three Months Ended
|
||||||
|
|
|
March 30,
2018 |
|
March 31,
2017 |
||||
|
|
|
(in millions)
|
||||||
|
Revenues:
|
|
|
|
|
||||
|
Defense Solutions
|
|
$
|
1,178
|
|
|
$
|
1,294
|
|
|
Civil
|
|
840
|
|
|
842
|
|
||
|
Health
|
|
425
|
|
|
443
|
|
||
|
Corporate
|
|
—
|
|
|
1
|
|
||
|
Total revenues
|
|
$
|
2,443
|
|
|
$
|
2,580
|
|
|
|
|
|
|
|
||||
|
Operating income (loss):
|
|
|
|
|
||||
|
Defense Solutions
|
|
$
|
85
|
|
|
$
|
79
|
|
|
Civil
|
|
74
|
|
|
54
|
|
||
|
Health
|
|
42
|
|
|
47
|
|
||
|
Corporate
|
|
(42
|
)
|
|
(39
|
)
|
||
|
Total operating income
|
|
$
|
159
|
|
|
$
|
141
|
|
|
|
|
Three Months Ended
|
|||||||||||||
|
|
|
March 30,
2018 |
|
March 31,
2017 |
|
Dollar change
|
|
Percent change
|
|||||||
|
|
|
(dollars in millions)
|
|||||||||||||
|
Revenues
|
|
$
|
2,443
|
|
|
$
|
2,580
|
|
|
$
|
(137
|
)
|
|
(5.3
|
)%
|
|
Operating income
|
|
159
|
|
|
141
|
|
|
18
|
|
|
12.8
|
%
|
|||
|
Non-operating expense, net
(1)
|
|
(34
|
)
|
|
(33
|
)
|
|
(1
|
)
|
|
3.0
|
%
|
|||
|
Income before income taxes
|
|
125
|
|
|
108
|
|
|
17
|
|
|
15.7
|
%
|
|||
|
Income tax expense
|
|
(23
|
)
|
|
(34
|
)
|
|
11
|
|
|
(32.4
|
)%
|
|||
|
Net income
|
|
102
|
|
|
74
|
|
|
28
|
|
|
37.8
|
%
|
|||
|
Net income attributable to Leidos common stockholders
|
|
$
|
102
|
|
|
$
|
72
|
|
|
$
|
30
|
|
|
41.7
|
%
|
|
Operating margin
|
|
6.5
|
%
|
|
5.5
|
%
|
|
|
|
|
|||||
|
|
|
Three Months Ended
|
|||||||||||||
|
Defense Solutions
|
|
March 30,
2018 |
|
March 31,
2017 |
|
Dollar change
|
|
Percent change
|
|||||||
|
|
|
(dollars in millions)
|
|||||||||||||
|
Revenues
|
|
$
|
1,178
|
|
|
$
|
1,294
|
|
|
$
|
(116
|
)
|
|
(9.0
|
)%
|
|
Operating income
|
|
85
|
|
|
79
|
|
|
6
|
|
|
7.6
|
%
|
|||
|
Operating margin
|
|
7.2
|
%
|
|
6.1
|
%
|
|
|
|
|
|||||
|
|
|
Three Months Ended
|
|||||||||||||
|
Civil
|
|
March 30,
2018 |
|
March 31,
2017 |
|
Dollar change
|
|
Percent change
|
|||||||
|
|
|
(dollars in millions)
|
|||||||||||||
|
Revenues
|
|
$
|
840
|
|
|
$
|
842
|
|
|
$
|
(2
|
)
|
|
(0.2
|
)%
|
|
Operating income
|
|
74
|
|
|
54
|
|
|
20
|
|
|
37.0
|
%
|
|||
|
Operating margin
|
|
8.8
|
%
|
|
6.4
|
%
|
|
|
|
|
|||||
|
|
|
Three Months Ended
|
|||||||||||||
|
Health
|
|
March 30,
2018 |
|
March 31,
2017 |
|
Dollar change
|
|
Percent change
|
|||||||
|
|
|
(dollars in millions)
|
|||||||||||||
|
Revenues
|
|
$
|
425
|
|
|
$
|
443
|
|
|
$
|
(18
|
)
|
|
(4.1
|
)%
|
|
Operating income
|
|
42
|
|
|
47
|
|
|
(5
|
)
|
|
(10.6
|
)%
|
|||
|
Operating margin
|
|
9.9
|
%
|
|
10.6
|
%
|
|
|
|
|
|||||
|
|
|
Three Months Ended
|
|||||||||||||
|
Corporate
|
|
March 30,
2018 |
|
March 31,
2017 |
|
Dollar change
|
|
Percent change
|
|||||||
|
|
|
(dollars in millions)
|
|||||||||||||
|
Revenues
|
|
$
|
—
|
|
|
$
|
1
|
|
|
$
|
(1
|
)
|
|
NM
|
|
|
Operating loss
|
|
(42
|
)
|
|
(39
|
)
|
|
(3
|
)
|
|
7.7
|
%
|
|||
|
|
|
March 30,
2018 |
|
December 29,
2017 |
||||
|
|
|
(in millions)
|
||||||
|
Defense Solutions:
|
|
|
|
|
||||
|
Funded backlog
|
|
$
|
2,162
|
|
|
$
|
2,384
|
|
|
Negotiated unfunded backlog
|
|
5,928
|
|
|
5,285
|
|
||
|
Total Defense Solutions backlog
|
|
$
|
8,090
|
|
|
$
|
7,669
|
|
|
Civil:
|
|
|
|
|
||||
|
Funded backlog
|
|
$
|
1,816
|
|
|
$
|
2,064
|
|
|
Negotiated unfunded backlog
|
|
5,458
|
|
|
5,321
|
|
||
|
Total Civil backlog
|
|
$
|
7,274
|
|
|
$
|
7,385
|
|
|
Health:
|
|
|
|
|
||||
|
Funded backlog
|
|
$
|
596
|
|
|
$
|
595
|
|
|
Negotiated unfunded backlog
|
|
1,648
|
|
|
1,827
|
|
||
|
Total Health backlog
|
|
$
|
2,244
|
|
|
$
|
2,422
|
|
|
Total:
|
|
|
|
|
||||
|
Funded backlog
|
|
$
|
4,574
|
|
|
$
|
5,043
|
|
|
Negotiated unfunded backlog
|
|
13,034
|
|
|
12,433
|
|
||
|
Total backlog
|
|
$
|
17,608
|
|
|
$
|
17,476
|
|
|
|
|
Three Months Ended
|
||||||
|
|
|
March 30,
2018 |
|
March 31,
2017 |
||||
|
|
|
(in millions)
|
||||||
|
Net cash provided by (used in) operating activities
|
|
$
|
22
|
|
|
$
|
(71
|
)
|
|
Net cash used in investing activities
|
|
(96
|
)
|
|
(5
|
)
|
||
|
Net cash used in financing activities
|
|
(91
|
)
|
|
(78
|
)
|
||
|
Net decrease in cash, cash equivalents and restricted cash
|
|
$
|
(165
|
)
|
|
$
|
(154
|
)
|
|
(a)
|
None
|
|
(b)
|
None
|
|
(c)
|
Purchases of Equity Securities by the Company
|
|
Period
|
|
Total Number of Shares
(or Units) Purchased (1) |
|
Average Price
Paid per Share (or Unit) |
|
Total Number of Shares
(or Units) Purchased as Part of Publicly Announced Repurchase Plans or Programs |
|
Maximum Number of Shares (or Units) that May Yet Be
Purchased Under the Plans or Programs |
|||||
|
December 30, 2017 - December 31, 2017
|
|
—
|
|
|
$
|
—
|
|
|
—
|
|
|
5,718,172
|
|
|
January 1, 2018 - January 31, 2018
|
|
4,858
|
|
|
64.16
|
|
|
—
|
|
|
5,718,172
|
|
|
|
February 1, 2018 - February 28, 2018
|
|
8,513
|
|
|
66.45
|
|
|
—
|
|
|
20,000,000
|
|
|
|
March 1, 2018 - March 30, 2018
|
|
150,642
|
|
|
68.49
|
|
|
145,185
|
|
|
19,854,815
|
|
|
|
Total
|
|
164,013
|
|
|
$
|
68.26
|
|
|
145,185
|
|
|
|
|
|
(1)
|
The total number of shares purchased includes shares surrendered to satisfy statutory tax withholdings obligations related to vesting of restricted stock units.
|
|
Exhibit
Number |
|
Description of Exhibit
|
|
10.1
|
|
|
|
31.1
|
|
|
|
|
|
|
|
31.2
|
|
|
|
|
|
|
|
32.1
|
|
|
|
|
|
|
|
32.2
|
|
|
|
|
|
|
|
101
|
|
Interactive Data File.
|
|
Leidos Holdings, Inc.
|
|
|
|
/s/ James C. Reagan
|
|
James C. Reagan
Executive Vice President and Chief Financial Officer and
as a duly authorized officer
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|